Table 1.
Sensitivity of biopsy kinds in different subtypes of sarcomas (CNB: Core needle biopsy; IB: Incisional biopsy; bolded p-value is a significant difference, p < 0.05).
| Subtypes of Sarcomas | Dignity | Entity | Grading | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CNB | IB | p | CNB | IB | p | CNB | IB | p | |
| Osteosarcoma | 39/52 (75%) | 26/32 (81.3%) | 0.506 | 45/52 (86.5%) | 28/32 (87.5%) | 0.899 | |||
| Chondrosarcoma | 38/57 (66.7%) | 18/20 (88.9%) | 0.024 | 45/57 (78.9%) | 18/20 (88.9%) | 0.270 | 29/57 (50.8%) | 14/20 (70.0%) | 0.181 |
| Ewing Sarcoma | 26/32 (81.3%) | 4/4 (100%) | 0.343 | 26/32 (81.3%) | 4/4 (100%) | 0.343 | |||
| Myxofibrosarcoma | 14/19 (73.7%) | 5/6 (83.3%) | 0.629 | 14/19 (73.7%) | 5/6 (83.3%) | 0.629 | 6/13 (46.2%) | 2/4 (50.0%) | 0.893 |
| Liposarcoma | 27/37 (73.0%) | 17/21 (81.0%) | 0.495 | 30/37 (81.1%) | 17/21 (81.0%) | 0.990 | 16/26 (61.5%) | 12/19 (63.2%) | 0.912 |
| MPNST | 13/15 (86.7%) | 3/5 (60.0%) | 0.197 | 13/15 (86.7%) | 4/5 (80.0%) | 0.718 | 2/7 (28.7%) | 1/2 (50.0%) | 0.571 |
| Synovialsarcoma | 6/6 (100%) | 8/9 (88.9%) | 0.398 | 6/6 (100%) | 9/9 (100%) | 2/2 (100%) | 2/3 (100%) | ||
| Leiomyo-/Rhabdomyosarcoma | 21/23 (91.3%) | 5/5 (100%) | 0.494 | 21/23 (91.3%) | 5/5 (100%) | 0.494 | 6/10 (60%) | 3/3 (100%) | 0.188 |
| Epithelioid Sarcoma | 7/9 (77.8%) | 2/2 (100%) | 8/9 (88.9%) | 2/2 (100%) | 0.621 | 5/6 (88.3%) | 0 | ||